Chinese Suppliers Funnel 5,000 Illegal Retatrutide Shipments Into US, Echoing Fentanyl Tactics
Updated
Updated · Fox News · Sep 2
Chinese Suppliers Funnel 5,000 Illegal Retatrutide Shipments Into US, Echoing Fentanyl Tactics
3 articles · Updated · Fox News · Sep 2
Summary
Customs officers in Cincinnati seized more than 300 master cartons from China holding about 5,000 peptide shipments, including retatrutide, exposing a direct pipeline of unapproved injectable drugs into U.S. homes.
Chainalysis and TRM Labs traced proceeds and supplier patterns linking some China-based peptide sellers to companies tied to fentanyl precursors or synthetic opioids, suggesting the same illicit trade infrastructure is being repurposed.
Sellers evade detection by mislabeling packages, using coded names such as "GLP-3 RT," and marking products "for research use only" while still providing syringes, dosing guides and injection videos.
The report argues the threat goes beyond unsafe weight-loss drugs because there is no lawful U.S. supply chain, no reliable recall mechanism and no way for buyers to verify sterility, purity or potency.
That framing pushes the issue from a pharmaceutical crackdown toward a broader national-security response involving DHS, DOJ, FDA, state law enforcement, payment firms, platforms and shippers.